Preventive treatment for schistosomiasis control is a priority objective for the Department of Health (DoH) in South Africa. The uMkhanyakude district of KwaZulu-Natal is one of the districts in which schistosomiasis in a major public... more
Preventive treatment for schistosomiasis control is a priority objective for the Department of Health (DoH) in South Africa. The uMkhanyakude district of KwaZulu-Natal is one of the districts in which schistosomiasis in a major public health concern. We mapped the unmet resource requirements for a schistosomiasis control mass drug administration (MDA) program targeting children aged five years old and below in the uMkhanyakude District. We interviewed 10 decision makers among the uMkhanyakude Health District staff in order to understand the resources that the district has and the resources that the district needs to implement a schistosomiasis control MDA program targeting children aged five years old and below in the uMkhanyakude district. We analyzed and reported on the resources based on the following categories: financing; coverage; program integration; monitoring and evaluation; infrastructure; materials; human resources and training. We identified the resources that the distri...
Background Schistosomiasis negatively impacts early childhood development. Inclusion of children aged five years and below in mass drug administration (MDA) programs for controlling schistosomiasis could improve early childhood... more
Background Schistosomiasis negatively impacts early childhood development. Inclusion of children aged five years and below in mass drug administration (MDA) programs for controlling schistosomiasis could improve early childhood development in communities where the disease is endemic. We estimated the projected cost of implementing a schistosomiasis control MDA program for children aged five years and below in the uMkhanyakude district of South Africa.Method We calculated the cost of implementing a schistosomiasis MDA program targeting children aged five years and below using an economies of scaled based cost function. We further compared different labor composition simulations to determine the most affordable and available human resources to implement the program. We also explored programs to which the MDA program could be integrated; and estimated what the costs for would be. Moreover, we simulated cost-effectiveness and determined the cost drivers for each simulation considered.Re...
Background: The early childhood development of millions of children in some low and medium income countries may be compromised by schistosomiasis infections contracted at the age of 5 years or below. Currently there are no standard... more
Background: The early childhood development of millions of children in some low and medium income countries may be compromised by schistosomiasis infections contracted at the age of 5 years or below. Currently there are no standard guidelines for treating schistosomiasis in children that are five years and younger using praziquantel (PZQ), the only drug that the WHO recommends to treat schistosomiasis. This review is on processes and resources involved in the treatment of schistosomiasis in children aged five years and below.Methods: An electronic search for peer-reviewed articles published in the period from 2008 to 2018 (August) was done in the Academic Search Complete, CINAHL with Full Text, Health Source: Nursing/Academic Edition, and MEDLINE databases via EBSCOHost and Google Scholar databases. The search targeted journals that described the treatment of schistosomiasis in children five years and below using praziquantel. Results: Twelve studies met the inclusion criteria. The ...
Interview guide. FMEA Interview Guide for Pediatric PZQ Administration in uMkhanyakude Health District. The interview guide that was used to obtain information for the FMEA of a prospective Schistosomiasis Preventive Mass Drug in the... more
Interview guide. FMEA Interview Guide for Pediatric PZQ Administration in uMkhanyakude Health District. The interview guide that was used to obtain information for the FMEA of a prospective Schistosomiasis Preventive Mass Drug in the uMkhanyakude District of KwaZulu-Natal. (DOCX 14 kb)
Background The early childhood development of millions of children in some low- and medium-income countries may be compromised by schistosomiasis infections contracted at the age of 5 years and below. Currently, there are no standard... more
Background The early childhood development of millions of children in some low- and medium-income countries may be compromised by schistosomiasis infections contracted at the age of 5 years and below. Currently, there are no standard guidelines for treating schistosomiasis in children that are 5 years and younger using praziquantel (PZQ), the only drug that the World Health Organization (WHO) recommends for treating schistosomiasis. The review is on processes and resources involved in the treatment of schistosomiasis in children aged 5 years and below. Methods An electronic search for peer-reviewed articles published in the period from January 2011 to August 2021 was done in the Academic Search Complete, CINAHL with Full Text, Health Source: Nursing/Academic Edition, and MEDLINE databases via EBSCOHost and Google Scholar databases. The search targeted journals that described the treatment of schistosomiasis in children 5 years and below using praziquantel. Results Thirteen studies m...
